NAD+ Boost Could Rewind Alzheimer’s Signs in Mice, Early Study Says
A Cell Reports Medicine study in two Alzheimer’s mouse models shows that restoring NAD+ balance can reverse key disease features and restore memory, with human brain tissue from severe cases showing similar NAD+ disruptions. While not a human trial and NAD+-targeted therapies aren’t approved, the findings suggest Alzheimer’s progression may stem from reversible cellular energy/repair failures and highlight NAD+ as a promising upstream target and lifestyle factor to support brain resilience.
